Stem cells in the eye: a new hope for dry AMD?

NCT ID NCT04339764

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times

Summary

This study tests whether transplanting lab-grown eye cells can help treat geographic atrophy, a severe form of dry age-related macular degeneration that causes blind spots. About 20 people aged 55 and older will receive a transplant of their own stem-cell-derived retinal cells into one eye. Participants will need to take immune-suppressing drugs to prevent rejection and will be followed for up to 15 years to check safety and vision changes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Johns Hopkins University

    NOT_YET_RECRUITING

    Baltimore, Maryland, 21205, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.